Interim Report 1 April - 30 September 2015

1 JULY - 30 SEPTEMBER 2015 (3 MONTHS)

  · Net sales rose by 11 percent to SEK 1,853 million (1,664).
  · Operating profit rose by 1 percent to SEK 141 million (140) and the
operating margin amounted to 7.7 percent (8.4).
  · Profit after financial items amounted to SEK 136 million (135).
  · Profit after tax amounted to SEK 106 million (103).
  · Earnings per share (EPS) totalled SEK 1.50 (1.50). For the most recent 12
-month period, earnings per share was SEK 6.05 (5.65).
  · Return on equity was 27 percent (29) and the equity ratio was 35 percent
(35).
  · Preparations for a separate listing on Nasdaq OMX Stockholm for the Life
Science business area, through a distribution of shares to Addtech’s
shareholders, are progressing according to plan. The parent company for Life
Science operations has been named AddLife AB and a Board of Directors and
management team for the company have been appointed.

1 APRIL - 30 SEPTEMBER 2015 (6 MONTHS)

  · Net sales rose by 12 percent to SEK 3,592 million (3,193).
  · Operating profit rose by 5 percent to SEK 280 million (267) and the
operating margin amounted to 7.8 percent (8.4).
  · Profit after financial items rose by 7 percent to SEK 273 million (254) and
profit after tax amounted to SEK 211 million (194).
  · Earnings per share (EPS) totalled SEK 3.05 (2.90).
  · Since the start of the financial year nine acquisitions made by the Group
have taken effect, three of which after the end of the period, adding sales of
about SEK 1,050 million on an annual basis.

This report has not been subject to review by the company's auditor.

The interim report for the period 1 April - 31 December 2015 will be published
on 9 February 2016.

For further information, please contact:
Johan Sjö President and CEO, +46 8 470 49 00
Kristina Willgård, CFO, +46 8 470 49 10